ROSE ADONIS: Open Payments
NPI 1760169619 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 15 payments from 6 companies in 2025. Trend: 2023 $157 · 2024 $1,798 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $273 |
| Axsome Therapeutics, Inc. | 4 | $182 |
| Janssen Pharmaceuticals, Inc | 3 | $174 |
| Alkermes, Inc. | 3 | $144 |
| ABBVIE INC. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, Auvelity, INVEGA SUSTENNA, LYBALVI, ARISTADA, VRAYLAR, Qelbree.
Industry payments across FL — which companies pay providers there.
